APA (7th ed.) Citation

Halton, J., Brandão, L. R., Luciani, M., Bomgaars, L., Chalmers, E., Mitchell, L. G., . . . Woods-Swafford, W. (2021). Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): A randomised, controlled, open-label, phase 2b/3, non-inferiority trial. The lancet. Haematology, 8(1), . https://doi.org/10.1016/S2352-3026(20)30368-9

Chicago Style (17th ed.) Citation

Halton, Jacqueline, et al. "Dabigatran Etexilate for the Treatment of Acute Venous Thromboembolism in Children (DIVERSITY): A Randomised, Controlled, Open-label, Phase 2b/3, Non-inferiority Trial." The Lancet. Haematology 8, no. 1 (2021). https://doi.org/10.1016/S2352-3026(20)30368-9.

MLA (9th ed.) Citation

Halton, Jacqueline, et al. "Dabigatran Etexilate for the Treatment of Acute Venous Thromboembolism in Children (DIVERSITY): A Randomised, Controlled, Open-label, Phase 2b/3, Non-inferiority Trial." The Lancet. Haematology, vol. 8, no. 1, 2021, https://doi.org/10.1016/S2352-3026(20)30368-9.